1-1 of 1
Ernesto Diaz-Flores
Close
Sort by
Journal Articles

CD22 low /Bcl-2 high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

Clinical Trials & Observations
Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, Courtney Tamaki, Joshua Fandel, Lingyun Ji, Brent L. Wood, Nirali N. Shah, Constance M. Yuan, Maureen M. O’Brien, Mignon L. Loh, Ernesto Diaz-Flores
Journal: Blood Advances
Blood Adv (2023) 7 (2): 251–255.
https://doi.org/10.1182/bloodadvances.2021006810
Published: 2023
Includes: Supplemental data